home / stock / nurpf / nurpf news
(NewsDirect) Neuren Pharmaceuticals Ltd (ASX:NEU) CEO Jon Pilcher speaks with Proactive following the news that its North America partner Acadia Pharmaceuticals has received US Food and Drug Administration approval of DAYBUE™ (trofinetide) for the treatment of Rett syndrome in adult an...
News, Short Squeeze, Breakout and More Instantly...
Neuren Pharms Ltd Ord Company Name:
NURPF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Neuren Pharmaceuticals Ltd (ASX:NEU) CEO Jon Pilcher speaks with Proactive following the news that its North America partner Acadia Pharmaceuticals has received US Food and Drug Administration approval of DAYBUE™ (trofinetide) for the treatment of Rett syndrome in adult an...